InvestorsHub Logo
Followers 139
Posts 23250
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Tuesday, 12/24/2019 11:48:49 AM

Tuesday, December 24, 2019 11:48:49 AM

Post# of 463616

Enrollment for the Phase 2 ANAVEX 2-73 Parkinson’s disease dementia study is expected to be completed by the end of December 2019 with top-line data expected mid-2020.



https://seekingalpha.com/article/4312820-anavex-life-sciences-corp-s-avxl-ceo-christopher-missling-on-q4-2019-results-earnings-call?part=single

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News